Cargando…

MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer

A major genomic alteration in prostate cancer (PCa) is frequent loss of chromosome (chr) 8p with a common region of loss of heterozygosity (LOH) at chr8p22 locus. Genomic studies implicate this locus in the initiation of clinically significant PCa and with progression to metastatic disease. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bucay, Nathan, Sekhon, Kirandeep, Yang, Thao, Majid, Shahana, Shahryari, Varahram, Hsieh, Christine, Mitsui, Yozo, Deng, Guoren, Tabatabai, Z. Laura, Yamamura, Soichiro, Calin, George A., Dahiya, Rajvir, Tanaka, Yuichiro, Saini, Sharanjot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426972/ https://www.ncbi.nlm.nih.gov/pubmed/27893706 http://dx.doi.org/10.1038/onc.2016.419

Ejemplares similares

Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer
por: Bucay, Nathan, et al.
Publicado: (2016)

MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases
por: Arora, Sumit, et al.
Publicado: (2013)

Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians
por: Shiina, Marisa, et al.
Publicado: (2016)

The role of miR-24 as a race related genetic factor in prostate cancer
por: Hashimoto, Yutaka, et al.
Publicado: (2017)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways
por: Mitsui, Yozo, et al.
Publicado: (2015)

Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer
por: Kato, Taku, et al.
Publicado: (2018)

LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma
por: Dasgupta, Pritha, et al.
Publicado: (2020)

Correction: Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2
por: Colden, Melissa, et al.
Publicado: (2017)

MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer
por: Majid, Shahana, et al.
Publicado: (2012)

Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151
por: Chiyomaru, Takeshi, et al.
Publicado: (2012)

Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer
por: Chiyomaru, Takeshi, et al.
Publicado: (2013)

Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer
por: Nip, Hannah, et al.
Publicado: (2016)

MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells
por: Yamamura, Soichiro, et al.
Publicado: (2012)

Suppressor effect of catechol-O-methyltransferase gene in prostate cancer
por: Hashimoto, Yutaka, et al.
Publicado: (2021)

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma
por: Mitsui, Yozo, et al.
Publicado: (2015)

Correction: CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma
por: Mitsui, Yozo, et al.
Publicado: (2022)

Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer
por: Majid, Shahana, et al.
Publicado: (2013)

Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma
por: Chang, Inik, et al.
Publicado: (2015)

DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells
por: Fukuhara, Shinichiro, et al.
Publicado: (2014)

MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer
por: Hirata, Hiroshi, et al.
Publicado: (2013)

Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells
por: Fukuhara, Shinichiro, et al.
Publicado: (2015)

Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer
por: Mitsui, Yozo, et al.
Publicado: (2016)

Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways
por: Imai-Sumida, Mitsuho, et al.
Publicado: (2017)

Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010)

Wnt signaling pathways in urological cancers: past decades and still growing
por: Majid, Shahana, et al.
Publicado: (2012)

Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans
por: Shiina, Marisa, et al.
Publicado: (2021)

Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer
por: Hirata, Hiroshi, et al.
Publicado: (2012)

Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
por: Chiyomaru, Takeshi, et al.
Publicado: (2013)

MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020)

Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation
por: Chang, Inik, et al.
Publicado: (2018)

Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation
por: Chang, Inik, et al.
Publicado: (2017)

Interaction and cross-talk between non-coding RNAs
por: Yamamura, Soichiro, et al.
Publicado: (2017)

MicroRNA-4287 is a novel tumor suppressor microRNA controlling epithelial-to mesenchymal transition in prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020)

Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor
por: Mitsui, Yozo, et al.
Publicado: (2014)

Versican is a potential therapeutic target in docetaxel-resistant prostate cancer
por: Arichi, Naoko, et al.
Publicado: (2015)

Cytotoxicity of curcumin against CD44(±) prostate cancer cells: Roles of miR-383 and miR-708
por: Panahizadeh, Reza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_osscnpptn2sfkbpncal7hu4tm7